Major conditions being studied include HCT/solid organ transplantation (66), type 1 diabetes (67), inflammatory bowel disease (68), and hemophilia (69), targeting HLA-A2, insulin/HiP2, carcinoembryonic antigen (CEA), and factor VIII, respectively. Here, CEACAM5 is linked to type 1 diabetes mellitus.